Pieris Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 07/02/2024 | 14,000 | $2,402 | 0.00% | 1.08% |
JPMORGAN CHASE & CO | 12/26/2024 | 0 | $0 | -100.00% | 0.00% |
US BANCORP \DE\ | 08/07/2024 | 0 | $0 | -100.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
NORTHERN TRUST CORP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
STATE STREET CORP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
VANGUARD GROUP INC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
BARCLAYS PLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
CITIGROUP INC | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
MORGAN STANLEY | 10/17/2024 | 0 | $0 | -100.00% | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 0 | $0 | -100.00% | 0.00% |
GROUP ONE TRADING, L.P. | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
COMMERCE BANK | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 0 | $0 | -100.00% | 0.00% |
BVF INC/IL | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
RAYMOND JAMES & ASSOCIATES | 07/19/2024 | 0 | $0 | -100.00% | 0.00% |
PRUDENTIAL FINANCIAL INC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 0 | $0 | -100.00% | 0.00% |
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
BLACKROCK INC. | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
CITADEL ADVISORS LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA SECURITIES, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
B. RILEY WEALTH ADVISORS, INC. | 08/19/2024 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA ADVISERS, LP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN | 08/06/2024 | 0 | $0 | -100.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
ALLWORTH FINANCIAL LP | 07/24/2024 | 0 | $0 | -100.00% | 0.00% |
CERITY PARTNERS LLC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
UBS GROUP AG | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
SQUAREPOINT OPS LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
SUMMIT TRAIL ADVISORS, LLC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
TRUVESTMENTS CAPITAL LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
XTX TOPCO LTD | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
KESTRA ADVISORY SERVICES, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
CM MANAGEMENT, LLC | 08/01/2024 | 0 | $0 | -100.00% | 0.00% |
LYNX1 CAPITAL MANAGEMENT LP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
Pieris Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 22 institutional investors and hedge funds held shares of Pieris Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Inc.: 0
B. Riley Wealth Management, Inc.: 39,000
FIRST QUADRANT LLC/CA: 0
Marshall Wace North America L.P.: 871,574
Alambic Investment Management, L.P.: 10,900
Leap Investments LP: 0
1.08% of Pieris Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.03 M shares in the last 24 months. This purchase volume represents approximately $27.56 M in transactions.